2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes

Type 2 diabetes is a major threat to human health in the 21st century. More than half a billion people may suffer from this pandemic disease in 2030, leading to a huge burden of cardiovascular complications. Recently, 2 novel antidiabetic agents, glucagon-like peptide 1 receptor agonists and sodium-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chern-En, Ueng, Kwo-Chang, Chao, Ting-Hsing, Lin, Tsung-Hsien, Wu, Yih-Jer, Wang, Kang-Ling, Sung, Shih-Hsien, Yeh, Hung-I, Li, Yi-Heng, Liu, Ping-Yen, Chang, Kuan-Cheng, Shyu, Kou-Gi, Huang, Jin-Long, Tsai, Cheng-Dao, Hung, Huei-Fong, Liu, Ming-En, Chao, Tze-Fan, Cheng, Shu-Meng, Cheng, Hao-Min, Chu, Pao-Hsien, Yin, Wei-Hsian, Wu, Yen-Wen, Chen, Wen-Jone, Lai, Wen-Ter, Lin, Shing-Jong, Yeh, San-Jou, Hwang, Juey-Jen, Hou, Charles Jia-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Recommendations on Asian Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627904/
https://www.ncbi.nlm.nih.gov/pubmed/36338159
http://dx.doi.org/10.1016/j.jacasi.2021.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627904/
https://www.ncbi.nlm.nih.gov/pubmed/36338159
http://dx.doi.org/10.1016/j.jacasi.2021.08.003

Ejemplares similares